214 related articles for article (PubMed ID: 28892043)
1. Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking.
Corkery DP; Clarke LE; Gebremeskel S; Salsman J; Pinder J; Le Page C; Meunier L; Xu Z; Mes-Masson AM; Berman JN; Johnston B; Dellaire G
Oncogene; 2018 Jan; 37(2):174-184. PubMed ID: 28892043
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor alpha (ESR1)-signaling regulates the expression of the taxane-response biomarker PRP4K.
Lahsaee S; Corkery DP; Anthes LE; Holly A; Dellaire G
Exp Cell Res; 2016 Jan; 340(1):125-31. PubMed ID: 26712520
[TBL] [Abstract][Full Text] [Related]
3. PRP4K is a HER2-regulated modifier of taxane sensitivity.
Corkery DP; Le Page C; Meunier L; Provencher D; Mes-Masson AM; Dellaire G
Cell Cycle; 2015; 14(7):1059-69. PubMed ID: 25602630
[TBL] [Abstract][Full Text] [Related]
4. Haploinsufficient tumor suppressor PRP4K is negatively regulated during epithelial-to-mesenchymal transition.
Clarke LE; Cook A; Mathavarajah S; Bera A; Salsman J; Habib E; Van Iderstine C; Bydoun M; Lewis SM; Dellaire G
FASEB J; 2021 Nov; 35(11):e22001. PubMed ID: 34674320
[TBL] [Abstract][Full Text] [Related]
5. ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells.
Khan IA; Yoo BH; Masson O; Baron S; Corkery D; Dellaire G; Attardi LD; Rosen KV
Oncogene; 2016 Nov; 35(44):5759-5769. PubMed ID: 27109096
[TBL] [Abstract][Full Text] [Related]
6. Curcumin induces radiosensitivity of in vitro and in vivo cancer models by modulating pre-mRNA processing factor 4 (Prp4).
Shehzad A; Park JW; Lee J; Lee YS
Chem Biol Interact; 2013 Nov; 206(2):394-402. PubMed ID: 24144778
[TBL] [Abstract][Full Text] [Related]
7. Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers.
Mehner C; Oberg AL; Kalli KR; Nassar A; Hockla A; Pendlebury D; Cichon MA; Goergen KM; Maurer MJ; Goode EL; Keeney GL; Jatoi A; Sahin-Tóth M; Copland JA; Radisky DC; Radisky ES
Oncotarget; 2015 Nov; 6(34):35737-54. PubMed ID: 26437224
[TBL] [Abstract][Full Text] [Related]
8. Tinker, Tailor, Tumour Suppressor: The Many Functions of PRP4K.
Habib EB; Mathavarajah S; Dellaire G
Front Genet; 2022; 13():839963. PubMed ID: 35281802
[TBL] [Abstract][Full Text] [Related]
9. Anoikis molecular pathways and its role in cancer progression.
Paoli P; Giannoni E; Chiarugi P
Biochim Biophys Acta; 2013 Dec; 1833(12):3481-3498. PubMed ID: 23830918
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
11. Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L).
Frankel A; Rosen K; Filmus J; Kerbel RS
Cancer Res; 2001 Jun; 61(12):4837-41. PubMed ID: 11406560
[TBL] [Abstract][Full Text] [Related]
12. Regulation of anoikis resistance by NADPH oxidase 4 and epidermal growth factor receptor.
Kim H; Sung JY; Park EK; Kho S; Koo KH; Park SY; Goh SH; Jeon YK; Oh S; Park BK; Jung YK; Kim YN
Br J Cancer; 2017 Jan; 116(3):370-381. PubMed ID: 28081539
[TBL] [Abstract][Full Text] [Related]
13. [Anoikis-suppression and invasion induced by tyrosine kinase receptor B in OVCAR3 ovarian cancer cells].
Yu XH; Yang YX; Cai B; Yan Q; He YY; Wan XP
Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):695-9. PubMed ID: 19087522
[TBL] [Abstract][Full Text] [Related]
14. CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR.
Bapat J; Yamamoto TM; Woodruff ER; Qamar L; Mikeska RG; Aird KM; Watson ZL; Brubaker LW; Bitler BG
Cancer Gene Ther; 2024 Feb; 31(2):300-310. PubMed ID: 38030811
[TBL] [Abstract][Full Text] [Related]
15. Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1.
Demers MJ; Thibodeau S; Noël D; Fujita N; Tsuruo T; Gauthier R; Arguin M; Vachon PH
J Cell Biochem; 2009 Jul; 107(4):639-54. PubMed ID: 19479902
[TBL] [Abstract][Full Text] [Related]
16. ERK-regulated αB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo.
Malin D; Strekalova E; Petrovic V; Rajanala H; Sharma B; Ugolkov A; Gradishar WJ; Cryns VL
Oncogene; 2015 Nov; 34(45):5626-34. PubMed ID: 25684139
[TBL] [Abstract][Full Text] [Related]
17. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis.
Reginato MJ; Mills KR; Paulus JK; Lynch DK; Sgroi DC; Debnath J; Muthuswamy SK; Brugge JS
Nat Cell Biol; 2003 Aug; 5(8):733-40. PubMed ID: 12844146
[TBL] [Abstract][Full Text] [Related]
18. Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes.
Koedoot E; Fokkelman M; Rogkoti VM; Smid M; van de Sandt I; de Bont H; Pont C; Klip JE; Wink S; Timmermans MA; Wiemer EAC; Stoilov P; Foekens JA; Le Dévédec SE; Martens JWM; van de Water B
Nat Commun; 2019 Jul; 10(1):2983. PubMed ID: 31278301
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells.
He X; Ota T; Liu P; Su C; Chien J; Shridhar V
Cancer Res; 2010 Apr; 70(8):3109-18. PubMed ID: 20388781
[TBL] [Abstract][Full Text] [Related]
20. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.
Douma S; Van Laar T; Zevenhoven J; Meuwissen R; Van Garderen E; Peeper DS
Nature; 2004 Aug; 430(7003):1034-9. PubMed ID: 15329723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]